By blocking the PD pathway, anti-PD-L1 antibody treatment prevents cancer immune evasion and induces antitumor immunity where activated CTLs migrate from lymphoid organs rich in immune cells into the tumor and kill cancer cells by inducing apoptosis. This evidence concerns the gene CD274 and cancer.